Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in March 02.03.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Investor and Scientific Conferences in March NEW YOR.
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.
DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in March 08.03.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Participate in Investor and Scientific Conferences in March N.
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused.
DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in March 08.03.2022 / 12:30 The issuer is solely responsible